#Carto system update#
#Carto system upgrade#

NCCIC recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities. Please see the Johnson & Johnson Product Security website for the latest security information for Products of the Johnson & Johnson Family of Companies: Users with questions regarding the CARTO 3 system are advised to contact their BWI sales representative or service technician.

#Carto system update#

Physical security for the CARTO 3 System is a critical control that must be employed by device users to limit the exposure of identified risks and vulnerabilities that can be exploited with persistent physical access to the device.īWI will be contacting users to initiate a software update in the field to address vulnerabilities within the CARTO 3 System.

BWI estimates these products are used primarily in the United States, Asia, Europe, Middle East, and Africa. According to BWI, CARTO 3 is deployed across the healthcare and public health sector. The affected product, the CARTO 3 V4 System, is an imaging device that uses electromagnetic technology to create real-time three-dimensional (3D) maps of a patient’s cardiac structures. 4.3 BACKGROUNDīWI, a Johnson & Johnson company, is a U.S.-based company that maintains offices in several countries around the world, including the U.S., Asia, Europe, Middle East, and Africa. These vulnerabilities require physical access to the CARTO 3 V4 System to exploit.Įxploits that target these vulnerabilities exist and are publicly available.Įxploiting these vulnerabilities would be difficult because an attacker must have physical access to the device and knowledge of the public exploits to exploit these vulnerabilities. Even if the CARTO 3 V4 System is networked, its network interface is restricted by a software firewall. These vulnerabilities cannot be exploited remotely. A table providing CVE numbers, Microsoft vulnerability tracking numbers, and titles can be found at the following link: 3.2 VULNERABILITY OVERVIEWīWI reported controlled risks in the CARTO 3 System related to operating system vulnerabilities and outdated anti-virus signatures. The following CARTO 3 Systems versions are affected:ĬARTO 3 Systems manufactured before April, 2018. NCCIC recommends that organizations evaluate the impact of these vulnerabilities based on their operational environment and specific clinical usage. Impact to individual organizations depends on many factors that are unique to each organization. If the CARTO 3 V4 System is networked, an attacker with persistent physical access may also be able to access other systems within the user’s network. This could allow the attacker to access information stored in the device, including individually identified health information about patients, affect the integrity of CARTO 3, or deny availability of the device. If an attacker has persistent physical access to a CARTO 3 V4 System, the attacker could exploit the vulnerabilities in the operating system. If the system is networked, the network interface for CARTO 3 V4 is sufficiently restricted by a software firewall to provide users reasonable assurance that it will not be exploited remotely or via malware/ransomware.

#Carto system upgrade#

This update will be applied to CARTO 3 Systems beginning in April, 2018 as part of the free-of-charge CARTO 3 Version 6 (V6) base software version, which is designed to upgrade compatible CARTO 3 Systems running Version 4 (V4). (BWI), a Johnson & Johnson company, has produced a software update that applies operating system patches and anti-virus signature updates to close known vulnerabilities in the operating system of the CARTO 3 System, a 3D cardiovascular mapping platform.